Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

  1. Wolff, I.
  2. May, M.
  3. Hoschke, B.
  4. Zigeuner, R.
  5. Cindolo, L.
  6. Hutterer, G.
  7. Schips, L.
  8. De Cobelli, O.
  9. Rocco, B.
  10. De Nunzio, C.
  11. Tubaro, A.
  12. Coman, I.
  13. Feciche, B.
  14. Truss, M.
  15. Dalpiaz, O.
  16. Figenshau, R.S.
  17. Madison, K.
  18. Sánchez-Chapado, M.
  19. Santiago Martin, M.D.C.
  20. Salzano, L.
  21. Lotrecchiano, G.
  22. Shariat, S.F.
  23. Hohenfellner, M.
  24. Waidelich, R.
  25. Stief, C.
  26. Miller, K.
  27. Pahernik, S.
  28. Brookman-May, S.
  29. Mostra tots els autors/es +
Revista:
European Journal of Surgical Oncology

ISSN: 1532-2157 0748-7983

Any de publicació: 2016

Volum: 42

Número: 5

Pàgines: 744-750

Tipus: Article

DOI: 10.1016/J.EJSO.2016.01.009 GOOGLE SCHOLAR